Eli Lilly
|
United States of America |
Biopharmaceuticals,
Drug Development & Therapeutics
|
$738
|
$698B |
13.7x |
34.8x |
AbbVie
|
United States of America |
Biopharmaceuticals,
Drug Development & Therapeutics,
Health & Beauty
|
$186
|
$393B |
6.8x |
15.1x |
Johnson & Johnson
|
United States of America |
Biopharmaceuticals,
Medical Devices,
Drug Development & Therapeutics
|
$155
|
$387B |
4.3x |
11.9x |
Merck & Co
|
United States of America |
Biopharmaceuticals,
Drug Development & Therapeutics,
Vaccines & Immunotherapies
|
$77
|
$219B |
3.4x |
8.0x |
Amgen
|
United States of America |
Biopharmaceuticals,
Drug Development & Therapeutics
|
$288
|
$204B |
6.0x |
10.6x |
Pfizer
|
United States of America |
Biopharmaceuticals,
Drug Development & Therapeutics,
Vaccines & Immunotherapies
|
$23
|
$178B |
2.8x |
7.3x |
Gilead Sciences
|
United States of America |
Biopharmaceuticals,
Drug Development & Therapeutics
|
$110
|
$154B |
5.4x |
12.5x |
Bristol-Myers Squibb
|
United States of America |
Biopharmaceuticals,
Drug Development & Therapeutics
|
$48
|
$138B |
2.9x |
12.1x |
Vertex Pharmaceuticals
|
United States of America |
Biopharmaceuticals,
Drug Development & Therapeutics,
Regenerative Medicine
|
$442
|
$109B |
9.6x |
39.7x |
Zoetis
|
United States of America |
Pet Care,
Biopharmaceuticals,
Drug Development & Therapeutics
|
$169
|
$80.1B |
8.6x |
20.0x |
Viatris
|
United States of America |
Biopharmaceuticals,
Drug Development & Therapeutics
|
$9
|
$23.8B |
1.7x |
5.4x |
Biogen
|
United States of America |
Biopharmaceuticals,
Drug Development & Therapeutics
|
$130
|
$23.0B |
2.4x |
7.1x |
Royalty Pharma
|
United States of America |
Biopharmaceuticals
|
$33
|
$19.7B |
6.8x |
7.4x |
Neurocrine Biosciences
|
United States of America |
Biopharmaceuticals,
Drug Development & Therapeutics
|
$123
|
$11.7B |
4.7x |
18.6x |
Organon
|
United States of America |
Biopharmaceuticals,
Drug Development & Therapeutics
|
$9
|
$10.8B |
1.7x |
5.5x |
Halozyme Therapeutics
|
United States of America |
Drug Development & Therapeutics,
Biopharmaceuticals
|
$56
|
$7.7B |
6.9x |
10.8x |
Amneal Pharmaceuticals
|
United States of America |
Biopharmaceuticals,
Drug Development & Therapeutics
|
$7
|
$4.8B |
1.7x |
7.5x |
ADMA Biologics
|
United States of America |
Biopharmaceuticals
|
$20
|
$4.7B |
10.3x |
24.4x |
Alvotech
|
United States of America |
Biopharmaceuticals,
Drug Development & Therapeutics
|
$11
|
$4.6B |
8.3x |
29.5x |
Alkermes
|
United States of America |
Biopharmaceuticals,
Drug Development & Therapeutics
|
$31
|
$4.2B |
2.9x |
10.8x |
Endo
|
United States of America |
Biopharmaceuticals,
Drug Development & Therapeutics
|
$21
|
$3.7B |
N/A |
N/A |
Procaps Group
|
United States of America |
Biopharmaceuticals,
Drug Development & Therapeutics,
Nutraceuticals & Cosmeceuticals
|
$1
|
$3.6B |
N/A |
N/A |
Scholar Rock
|
United States of America |
Drug Development & Therapeutics,
Biopharmaceuticals
|
$29
|
$2.5B |
836.6x |
-9.6x |
Ascentage Pharma
|
United States of America |
Biopharmaceuticals,
Drug Development & Therapeutics
|
$26
|
$2.3B |
20.7x |
-31.3x |
Metsera
|
United States of America |
Biopharmaceuticals,
Drug Development & Therapeutics
|
$27
|
$2.2B |
N/A |
N/A |
Belite Bio
|
United States of America |
Drug Development & Therapeutics,
Biopharmaceuticals
|
$65
|
$2.0B |
286.1x |
N/A |
ANI Pharmaceuticals
|
United States of America |
Biopharmaceuticals,
Drug Development & Therapeutics
|
$59
|
$1.8B |
2.6x |
10.1x |
Kiniksa Pharmaceuticals
|
United States of America |
Biopharmaceuticals,
Drug Development & Therapeutics
|
$27
|
$1.7B |
3.5x |
-1348.1x |
Amphastar Pharma
|
United States of America |
Biopharmaceuticals,
Drug Development & Therapeutics
|
$26
|
$1.6B |
2.2x |
5.8x |
Collegium Pharmaceutical
|
United States of America |
Biopharmaceuticals,
Drug Development & Therapeutics
|
$29
|
$1.6B |
2.3x |
3.8x |
Tarsus Pharmaceuticals
|
United States of America |
Drug Development & Therapeutics,
Biopharmaceuticals
|
$43
|
$1.5B |
5.4x |
-17.9x |
Arcutis Biotherapeutics
|
United States of America |
Drug Development & Therapeutics,
Biopharmaceuticals
|
$13
|
$1.5B |
6.0x |
-14.6x |
Travere Therapeutics
|
United States of America |
Drug Development & Therapeutics,
Biopharmaceuticals
|
$15
|
$1.4B |
4.8x |
-9.8x |
Supernus Pharmaceuticals
|
United States of America |
Biopharmaceuticals,
Drug Development & Therapeutics
|
$32
|
$1.3B |
2.1x |
7.8x |
NewAmsterdam Pharma Co
|
United States of America |
Drug Development & Therapeutics,
Biopharmaceuticals
|
$18
|
$1.2B |
35.3x |
N/A |
Innoviva
|
United States of America |
Drug Development & Therapeutics,
Biopharmaceuticals
|
$20
|
$1.2B |
3.4x |
N/A |
Harrow
|
United States of America |
Biopharmaceuticals,
Drug Development & Therapeutics
|
$28
|
$1.2B |
5.1x |
21.8x |
OPKO Health
|
United States of America |
Biopharmaceuticals,
Medical Imaging & Diagnostics
|
$1
|
$1.1B |
1.7x |
-7.7x |
Xeris Biopharma
|
United States of America |
Biopharmaceuticals,
Drug Development & Therapeutics
|
$5
|
$1000M |
4.4x |
67.3x |
Disc Medicine
|
United States of America |
Drug Development & Therapeutics,
Biopharmaceuticals
|
$47
|
$953M |
N/A |
-6.1x |
Emergent BioSolutions
|
United States of America |
Biopharmaceuticals,
Drug Development & Therapeutics
|
$6
|
$860M |
0.9x |
5.1x |
89bio
|
United States of America |
Drug Development & Therapeutics,
Biopharmaceuticals
|
$10
|
$834M |
N/A |
-2.3x |
Aurinia Pharmaceuticals
|
United States of America |
Drug Development & Therapeutics,
Biopharmaceuticals
|
$8
|
$823M |
3.4x |
N/A |
Ardelyx
|
United States of America |
Drug Development & Therapeutics,
Biopharmaceuticals
|
$4
|
$818M |
2.4x |
-48.5x |
Avadel Pharmaceuticals
|
United States of America |
Biopharmaceuticals,
Drug Development & Therapeutics
|
$9
|
$818M |
4.0x |
146.3x |
Dynavax
|
United States of America |
Biopharmaceuticals,
Drug Development & Therapeutics,
Vaccines & Immunotherapies
|
$10
|
$798M |
2.7x |
21.2x |
Oculis Holding
|
United States of America |
Drug Development & Therapeutics,
Biopharmaceuticals
|
$19
|
$795M |
928.3x |
-8.2x |
Spyre Therapeutics
|
United States of America |
Drug Development & Therapeutics,
Biopharmaceuticals
|
$15
|
$768M |
N/A |
-3.6x |
Akebia Therapeutics
|
United States of America |
Biopharmaceuticals,
Drug Development & Therapeutics
|
$3
|
$737M |
4.2x |
N/A |
WAVE Life Sciences
|
United States of America |
Drug Development & Therapeutics,
Biopharmaceuticals
|
$6
|
$707M |
7.9x |
-4.9x |
Mineralys Therapeutics
|
United States of America |
Drug Development & Therapeutics,
Biopharmaceuticals
|
$16
|
$672M |
N/A |
-3.5x |
Nika Pharmaceuticals
|
United States of America |
Biopharmaceuticals,
Drug Development & Therapeutics,
Nutraceuticals & Cosmeceuticals
|
$1
|
$667M |
N/A |
N/A |
Pharvaris
|
United States of America |
Drug Development & Therapeutics,
Biopharmaceuticals
|
$17
|
$634M |
N/A |
-3.7x |
LENZ Therapeutics
|
United States of America |
Drug Development & Therapeutics,
Biopharmaceuticals
|
$29
|
$629M |
219.1x |
-9.2x |
Ironwood Pharmaceuticals
|
United States of America |
Biopharmaceuticals,
Drug Development & Therapeutics
|
$1
|
$588M |
1.8x |
5.8x |
Enliven Therapeutics
|
United States of America |
Drug Development & Therapeutics,
Biopharmaceuticals
|
$18
|
$582M |
196966.7x |
-5.0x |
Elite Pharmaceuticals
|
United States of America |
Biopharmaceuticals,
Drug Development & Therapeutics
|
$1
|
$580M |
N/A |
N/A |
ArriVent BioPharma
|
United States of America |
Drug Development & Therapeutics,
Biopharmaceuticals
|
$21
|
$551M |
N/A |
-6.3x |
Zymeworks
|
United States of America |
Drug Development & Therapeutics,
Biopharmaceuticals
|
$11
|
$549M |
6.3x |
-4.4x |
Arbutus Biopharma
|
United States of America |
Drug Development & Therapeutics,
Biopharmaceuticals
|
$3
|
$532M |
88.2x |
N/A |
Anavex Life Sciences
|
United States of America |
Drug Development & Therapeutics,
Biopharmaceuticals
|
$8
|
$525M |
N/A |
N/A |
Cogent Biosciences
|
United States of America |
Drug Development & Therapeutics,
Biopharmaceuticals
|
$5
|
$499M |
N/A |
-2.3x |
Sana Biotechnology
|
United States of America |
Drug Development & Therapeutics,
Biopharmaceuticals
|
$2
|
$476M |
N/A |
-2.1x |
Praxis Precision Medicines
|
United States of America |
Drug Development & Therapeutics,
Biopharmaceuticals
|
$39
|
$458M |
84.5x |
-2.0x |
CytoDyn
|
United States of America |
Drug Development & Therapeutics,
Biopharmaceuticals
|
$0
|
$432M |
N/A |
N/A |
Syndax
|
United States of America |
Drug Development & Therapeutics,
Biopharmaceuticals
|
$11
|
$392M |
6.2x |
-1.2x |
ORIC Pharmaceuticals
|
United States of America |
Drug Development & Therapeutics,
Biopharmaceuticals
|
$8
|
$378M |
N/A |
-2.7x |
Mind Medicine
|
United States of America |
Drug Development & Therapeutics,
Biopharmaceuticals
|
$7
|
$358M |
N/A |
-3.2x |
Esperion Therapeutics
|
United States of America |
Biopharmaceuticals,
Drug Development & Therapeutics
|
$1
|
$351M |
1.0x |
10.0x |
Sionna Therapeutics
|
United States of America |
Biopharmaceuticals,
Drug Development & Therapeutics
|
$14
|
$343M |
N/A |
-4.1x |
Alpha Teknova
|
United States of America |
Contract Research & Manufacturing,
Biopharmaceuticals,
Drug Development & Therapeutics
|
$6
|
$311M |
8.0x |
-24.4x |
Dianthus Therapeutics
|
United States of America |
Drug Development & Therapeutics,
Biopharmaceuticals
|
$17
|
$297M |
56.9x |
N/A |
Celcuity
|
United States of America |
Drug Development & Therapeutics,
Biopharmaceuticals
|
$11
|
$296M |
N/A |
-2.3x |
Altimmune
|
United States of America |
Drug Development & Therapeutics,
Biopharmaceuticals
|
$5
|
$292M |
21180.3x |
-2.7x |
Phathom Pharmaceuticals
|
United States of America |
Drug Development & Therapeutics,
Biopharmaceuticals
|
$4
|
$287M |
2.9x |
-1.3x |
Nuvation Bio
|
United States of America |
Drug Development & Therapeutics,
Biopharmaceuticals
|
$2
|
$271M |
26.1x |
N/A |
SIGA Technologies
|
United States of America |
Biopharmaceuticals,
Drug Development & Therapeutics
|
$6
|
$266M |
2.0x |
4.1x |
Regenxbio
|
United States of America |
Drug Development & Therapeutics,
Biopharmaceuticals
|
$9
|
$256M |
1.4x |
-2.5x |
Aura Biosciences
|
United States of America |
Drug Development & Therapeutics,
Biopharmaceuticals
|
$6
|
$254M |
N/A |
N/A |
Savara
|
United States of America |
Drug Development & Therapeutics,
Biopharmaceuticals
|
$2
|
$251M |
N/A |
N/A |
Cullinan Therapeutics
|
United States of America |
Drug Development & Therapeutics,
Biopharmaceuticals
|
$9
|
$207M |
69.4x |
-1.0x |
Armata Pharmaceuticals
|
United States of America |
Biopharmaceuticals,
Drug Development & Therapeutics
|
$2
|
$194M |
36.5x |
-4.3x |
Alumis
|
United States of America |
Drug Development & Therapeutics,
Biopharmaceuticals
|
$3
|
$184M |
25.0x |
-0.6x |
Tourmaline Bio
|
United States of America |
Drug Development & Therapeutics,
Biopharmaceuticals
|
$17
|
$179M |
65.0x |
N/A |
Day One Biopharmaceutical
|
United States of America |
Drug Development & Therapeutics,
Biopharmaceuticals
|
$6
|
$177M |
1.3x |
-0.9x |
MBX Biosciences
|
United States of America |
Drug Development & Therapeutics,
Biopharmaceuticals
|
$12
|
$175M |
N/A |
-2.1x |
Tyra Biosciences
|
United States of America |
Drug Development & Therapeutics,
Biopharmaceuticals
|
$9
|
$171M |
N/A |
-1.5x |
Maze Therapeutics
|
United States of America |
Biopharmaceuticals,
Drug Development & Therapeutics,
Digital Therapeutics
|
$10
|
$168M |
1.7x |
-6.3x |
Wellgistics Health
|
United States of America |
Medical Devices,
Biopharmaceuticals
|
$2
|
$168M |
N/A |
N/A |
Xencor
|
United States of America |
Drug Development & Therapeutics,
Biopharmaceuticals
|
$8
|
$168M |
1.5x |
-0.9x |
Stoke Therapeutics
|
United States of America |
Drug Development & Therapeutics,
Biopharmaceuticals
|
$10
|
$166M |
1.8x |
-2.6x |
Arcturus Therapeutics
|
United States of America |
Drug Development & Therapeutics,
Biopharmaceuticals
|
$13
|
$166M |
1.3x |
-1.5x |
Y-mAbs Therapeutics
|
United States of America |
Drug Development & Therapeutics,
Biopharmaceuticals
|
$5
|
$149M |
1.8x |
-4.0x |
Erasca
|
United States of America |
Drug Development & Therapeutics,
Biopharmaceuticals
|
$1
|
$141M |
N/A |
-0.8x |
OmniAb
|
United States of America |
Drug Development & Therapeutics,
Biopharmaceuticals
|
$1
|
$135M |
5.4x |
-3.1x |
Lexicon Pharmaceuticals
|
United States of America |
Drug Development & Therapeutics,
Biopharmaceuticals
|
$1
|
$134M |
6.7x |
-0.8x |
UroGen Pharma
|
United States of America |
Drug Development & Therapeutics,
Biopharmaceuticals
|
$4
|
$124M |
1.2x |
-1.3x |
Septerna
|
United States of America |
Biopharmaceuticals,
Drug Development & Therapeutics,
Small Molecules
|
$9
|
$101M |
1.8x |
-1.4x |
Protalix
|
United States of America |
Biopharmaceuticals
|
$2
|
$93.9M |
1.5x |
N/A |
Silence Therapeutics
|
United States of America |
Drug Development & Therapeutics,
Biopharmaceuticals
|
$2
|
$88.8M |
3.2x |
-1.6x |